Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Longacre, Teri A."" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-3 z 3
    Tytuł:
    PAM staining intensity of primary neuroendocrine neoplasms is a potential prognostic biomarker.
    Autorzy:
    Horton TM; Department of Chemistry, Stanford University, Stanford, CA, USA.; Chemistry, Engineering and Medicine for Human Health (ChEM-H) Institute, Stanford University, Stanford, CA, USA.
    Sundaram V; Quantitative Sciences Unit, Department of Medicine, Stanford University, Stanford, CA, USA.
    Lee CH; Division of Endocrinology, Department of Medicine, Stanford University, CCSR 2255-A, 1291 Welch Rd., Stanford, CA, 94305-5165, USA.
    Hornbacker K; Endocrine Oncology Program, Stanford University, Stanford, USA.; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA, USA.
    Van Vleck A; Division of Endocrinology, Department of Medicine, Stanford University, CCSR 2255-A, 1291 Welch Rd., Stanford, CA, 94305-5165, USA.
    Benjamin KN; Department of Bioengineering, Stanford University, Stanford, CA, USA.
    Zemek A; Department of Pathology, Stanford University, Stanford, CA, USA.
    Longacre TA; Department of Pathology, Stanford University, Stanford, CA, USA.
    Kunz PL; Endocrine Oncology Program, Stanford University, Stanford, USA.; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA, USA.
    Annes JP; Chemistry, Engineering and Medicine for Human Health (ChEM-H) Institute, Stanford University, Stanford, CA, USA. .; Division of Endocrinology, Department of Medicine, Stanford University, CCSR 2255-A, 1291 Welch Rd., Stanford, CA, 94305-5165, USA. .; Endocrine Oncology Program, Stanford University, Stanford, USA. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2020 Jul 02; Vol. 10 (1), pp. 10943. Date of Electronic Publication: 2020 Jul 02.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Amidine-Lyases/*metabolism
    Biomarkers, Tumor/*metabolism
    Immunohistochemistry/*methods
    Mixed Function Oxygenases/*metabolism
    Neuroendocrine Tumors/*pathology
    Aged ; Aged, 80 and over ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neuroendocrine Tumors/metabolism ; Neuroendocrine Tumors/surgery ; Prognosis ; Survival Rate
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Template for Reporting Results of Biomarker Testing of Specimens From Patients With Carcinoma of the Endometrium.
    Autorzy:
    Longacre TA; From the Department of Pathology, Stanford Medicine, Stanford, California (Dr Longacre); the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Dr Broaddus); the Department of Obstetrics, Gynecology and Reproductive Science, Hess Center for Science and Medicine, Sinai Medical Center, New York, New York (Dr Chuang); the Department of Pathology, Huntsman Cancer Hospital, Salt Lake City, Utah (Dr Cohen); the Department of Pathology, University of Utah, Salt Lake City (Dr Jarboe); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Mutter); the Department of Pathology, Baystate Medical Center, Springfield, Massachusetts (Dr Otis); and the Department of Pathology, Penn State Hershey Medical Center, Hershey, Pennsylvania (Dr Zaino).
    Broaddus R; From the Department of Pathology, Stanford Medicine, Stanford, California (Dr Longacre); the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Dr Broaddus); the Department of Obstetrics, Gynecology and Reproductive Science, Hess Center for Science and Medicine, Sinai Medical Center, New York, New York (Dr Chuang); the Department of Pathology, Huntsman Cancer Hospital, Salt Lake City, Utah (Dr Cohen); the Department of Pathology, University of Utah, Salt Lake City (Dr Jarboe); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Mutter); the Department of Pathology, Baystate Medical Center, Springfield, Massachusetts (Dr Otis); and the Department of Pathology, Penn State Hershey Medical Center, Hershey, Pennsylvania (Dr Zaino).
    Chuang LT; From the Department of Pathology, Stanford Medicine, Stanford, California (Dr Longacre); the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Dr Broaddus); the Department of Obstetrics, Gynecology and Reproductive Science, Hess Center for Science and Medicine, Sinai Medical Center, New York, New York (Dr Chuang); the Department of Pathology, Huntsman Cancer Hospital, Salt Lake City, Utah (Dr Cohen); the Department of Pathology, University of Utah, Salt Lake City (Dr Jarboe); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Mutter); the Department of Pathology, Baystate Medical Center, Springfield, Massachusetts (Dr Otis); and the Department of Pathology, Penn State Hershey Medical Center, Hershey, Pennsylvania (Dr Zaino).
    Cohen MB; From the Department of Pathology, Stanford Medicine, Stanford, California (Dr Longacre); the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Dr Broaddus); the Department of Obstetrics, Gynecology and Reproductive Science, Hess Center for Science and Medicine, Sinai Medical Center, New York, New York (Dr Chuang); the Department of Pathology, Huntsman Cancer Hospital, Salt Lake City, Utah (Dr Cohen); the Department of Pathology, University of Utah, Salt Lake City (Dr Jarboe); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Mutter); the Department of Pathology, Baystate Medical Center, Springfield, Massachusetts (Dr Otis); and the Department of Pathology, Penn State Hershey Medical Center, Hershey, Pennsylvania (Dr Zaino).
    Jarboe EA; From the Department of Pathology, Stanford Medicine, Stanford, California (Dr Longacre); the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Dr Broaddus); the Department of Obstetrics, Gynecology and Reproductive Science, Hess Center for Science and Medicine, Sinai Medical Center, New York, New York (Dr Chuang); the Department of Pathology, Huntsman Cancer Hospital, Salt Lake City, Utah (Dr Cohen); the Department of Pathology, University of Utah, Salt Lake City (Dr Jarboe); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Mutter); the Department of Pathology, Baystate Medical Center, Springfield, Massachusetts (Dr Otis); and the Department of Pathology, Penn State Hershey Medical Center, Hershey, Pennsylvania (Dr Zaino).
    Mutter GL; From the Department of Pathology, Stanford Medicine, Stanford, California (Dr Longacre); the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Dr Broaddus); the Department of Obstetrics, Gynecology and Reproductive Science, Hess Center for Science and Medicine, Sinai Medical Center, New York, New York (Dr Chuang); the Department of Pathology, Huntsman Cancer Hospital, Salt Lake City, Utah (Dr Cohen); the Department of Pathology, University of Utah, Salt Lake City (Dr Jarboe); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Mutter); the Department of Pathology, Baystate Medical Center, Springfield, Massachusetts (Dr Otis); and the Department of Pathology, Penn State Hershey Medical Center, Hershey, Pennsylvania (Dr Zaino).
    Otis CN; From the Department of Pathology, Stanford Medicine, Stanford, California (Dr Longacre); the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Dr Broaddus); the Department of Obstetrics, Gynecology and Reproductive Science, Hess Center for Science and Medicine, Sinai Medical Center, New York, New York (Dr Chuang); the Department of Pathology, Huntsman Cancer Hospital, Salt Lake City, Utah (Dr Cohen); the Department of Pathology, University of Utah, Salt Lake City (Dr Jarboe); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Mutter); the Department of Pathology, Baystate Medical Center, Springfield, Massachusetts (Dr Otis); and the Department of Pathology, Penn State Hershey Medical Center, Hershey, Pennsylvania (Dr Zaino).
    Zaino RJ; From the Department of Pathology, Stanford Medicine, Stanford, California (Dr Longacre); the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Dr Broaddus); the Department of Obstetrics, Gynecology and Reproductive Science, Hess Center for Science and Medicine, Sinai Medical Center, New York, New York (Dr Chuang); the Department of Pathology, Huntsman Cancer Hospital, Salt Lake City, Utah (Dr Cohen); the Department of Pathology, University of Utah, Salt Lake City (Dr Jarboe); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Mutter); the Department of Pathology, Baystate Medical Center, Springfield, Massachusetts (Dr Otis); and the Department of Pathology, Penn State Hershey Medical Center, Hershey, Pennsylvania (Dr Zaino).
    Pokaż więcej
    Corporate Authors:
    Members of the Cancer Biomarker Reporting Committee, College of American Pathologists; From the Department of Pathology, Stanford Medicine, Stanford, California (Dr Longacre); the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Dr Broaddus); the Department of Obstetrics, Gynecology and Reproductive Science, Hess Center for Science and Medicine, Sinai Medical Center, New York, New York (Dr Chuang); the Department of Pathology, Huntsman Cancer Hospital, Salt Lake City, Utah (Dr Cohen); the Department of Pathology, University of Utah, Salt Lake City (Dr Jarboe); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Mutter); the Department of Pathology, Baystate Medical Center, Springfield, Massachusetts (Dr Otis); and the Department of Pathology, Penn State Hershey Medical Center, Hershey, Pennsylvania (Dr Zaino).
    Źródło:
    Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2017 Nov; Vol. 141 (11), pp. 1508-1512. Date of Electronic Publication: 2017 Mar 16.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Biomarkers, Tumor/*analysis
    Carcinoma/*metabolism
    Endometrial Neoplasms/*metabolism
    Research Report/*standards
    Carcinoma/diagnosis ; Endometrial Neoplasms/diagnosis ; Endometrium/metabolism ; Endometrium/pathology ; Female ; Guidelines as Topic/standards ; Humans
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Myogenin expression in vulvovaginal spindle cell lesions: analysis of a series of cases with an emphasis on diagnostic pitfalls.
    Autorzy:
    McCluggage WG; Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK.
    Longacre TA
    Fisher C
    Pokaż więcej
    Źródło:
    Histopathology [Histopathology] 2013 Oct; Vol. 63 (4), pp. 545-50. Date of Electronic Publication: 2013 Aug 14.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Diagnosis, Differential*
    Biomarkers, Tumor/*analysis
    Carcinoma, Squamous Cell/*diagnosis
    Myogenin/*biosynthesis
    Polyps/*diagnosis
    Vaginal Neoplasms/*diagnosis
    Adult ; Carcinoma, Squamous Cell/metabolism ; Female ; Humans ; Immunohistochemistry ; Middle Aged ; Myogenin/analysis ; Polyps/metabolism ; Rhabdomyosarcoma/diagnosis ; Vaginal Neoplasms/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-3 z 3

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies